BioCatalyst

Livmoniplimab, Budigalimab, Docetaxel, Paclitaxel — catalyst calendar

1 verified catalyst event(s) referencing Livmoniplimab, Budigalimab, Docetaxel, Paclitaxel, each linked to its official source. Verified as of 2026-11-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous
Phase 2 · Urothelial Carcinoma
 ABBV AbbVie Inc. Livmoniplimab, Budigalimab, Docetaxel, P ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.